Sentante takes physical AI to market, beginning commercial rollout in vascular surgery and interventional radiology
Following its May 2026 CE mark, Sentante is deploying first in the specialties its platform was built to serve, and where the multi-modal data that trains endovascular physical AI accumulates from the first commercial case KAUNAS, Lithuania, Aug. 25, 2026 /PRNewswire/ — Sentante, the medical robotics company building a haptic, device-agnostic platform for remote vascular […]

















































